Literature DB >> 9728754

Performance enhancing drugs (doping agents) and sudden death--a case report and review of the literature.

R Hausmann1, S Hammer, P Betz.   

Abstract

The case of sudden cardiac death of a 23-year-old body builder who used anabolic steroids combined with other performance enhancing drugs is reported. Postmortem investigations revealed cardiac hypertrophy, acute cellular necrosis and interstitial fibrosis of the myocardium. The side-effects and interactions of the substances used are discussed.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9728754     DOI： 10.1007/s004140050165

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN： 0937-9827            Impact factor:   2.686


  18 in total

Review 1.  Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2008-07-02       Impact factor: 4.492

Review 2.  Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders.

Authors:  Vittorio Fineschi; Irene Riezzo; Fabio Centini; Enrico Silingardi; Manuela Licata; Giovanni Beduschi; Steven B Karch
Journal:  Int J Legal Med       Date:  2005-11-15       Impact factor: 2.686

Review 3.  An Abductive Inference Approach to Assess the Performance-Enhancing Effects of Drugs Included on the World Anti-Doping Agency Prohibited List.

Authors:  Andreas Breenfeldt Andersen; Glenn A Jacobson; Jacob Bejder; Dino Premilovac; Stephen M Richards; Jon J Rasmussen; Søren Jessen; Morten Hostrup
Journal:  Sports Med       Date:  2021-04-02       Impact factor: 11.136

4.  [Cardiovascular alterations associated with doping].

Authors:  D Thieme; A Büttner
Journal:  Herz       Date:  2015-05       Impact factor: 1.443

Review 5.  Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm.

Authors:  Suraj Achar; Armand Rostamian; Sanjiv M Narayan
Journal:  Am J Cardiol       Date:  2010-09-15       Impact factor: 2.778

6.  Anabolic androgenic steroid induced myocardial toxicity: an evolving problem in an ageing population.

Authors:  Richard D Rothman; Rory B Weiner; Harrison Pope; Gen Kanayama; Adolph M Hutter; Michael A Fifer; G William Dec; Aaron L Baggish
Journal:  BMJ Case Rep       Date:  2011-08-17

Review 7.  The diagnostic dilemma of pathological appearance and performance enhancing drug use.

Authors:  Tom Hildebrandt; Justine K Lai; James W Langenbucher; Melanie Schneider; Rachel Yehuda; Donald W Pfaff
Journal:  Drug Alcohol Depend       Date:  2010-11-05       Impact factor: 4.492

Review 8.  Steroid use and long-term health risks in former athletes.

Authors:  Miia Pärssinen; Timo Seppälä
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

9.  Ventricular androgenic-anabolic steroid-related remodeling: an immunohistochemical study.

Authors:  Rossana Cecchi; Barbara Muciaccia; Costantino Ciallella; Natale Mario Di Luca; Akihiko Kimura; Cristina Sestili; Mizuho Nosaka; Toshikazu Kondo
Journal:  Int J Legal Med       Date:  2017-04-21       Impact factor: 2.686

Review 10.  Effects of androgenic-anabolic steroids in athletes.

Authors:  Fred Hartgens; Harm Kuipers
Journal:  Sports Med       Date:  2004       Impact factor: 11.136
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.